CUH

Additional approvals

Starting a project

Additional external approvals is required from the MHRA if the research involves the use of medicines or medical devices and the practical and safety issues will need to be addressed before the project starts with the CUH Pharmacy and Medical Engineering departments which are responsible for these aspects of safety.

 

Additional internal safeguards are also required for projects involving ionising radiation, patient data or human tissues.

 

The R&D Department has regular contact with all these organisations and can help ensure that all external and internal approvals are properly managed.

 

 

 

Projects involving Medicines

Approval in principle by the MHRA as well as internal approval on matters of practicality by the Trust's Pharmacy Department. It is best to consult Pharmacy at an early stage when designing a study. Please read their Guidance Note here.

 

 

Projects involving Medical Devices

Approval in principle by the MHRA as well as internal approval on matters of practicality by the Trust's Medical Engineering Department for the use of devices.

 

> Medical Devices

 

 

What is a Medical Device?

 

DIRECTIVE 2007/47/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 September 2007, which amended the COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices, defines a 'medical device' as:

 

any instrument, apparatus, appliance, software, material or other article, whether used alone or in combination, including the software intended by its manufacturer to be used specifically for diagnostic and/or therapeutic purposes and necessary for its proper application, intended by the manufacturer to be used for human beings for the purpose of:

  • diagnosis, prevention, monitoring, treatment or alleviation of disease,
  • diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap,
  • investigation, replacement or modification of the anatomy or of a physiological process,
  • control of conception,

and which does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function by such means.

 

 

Projects involving ionising radiation

Will require approval by the Trust's Radiology Department or the Wolfson Brain Imaging Centre.

 

 

 

Projects involving Patient data

All studies involving the use of patient data must be reviewed and approved by Data Protection Department.

 

 

 

See also:

> Tissue Bank

 

 

 

 

 

Back to top

 

 

 

Latest news

 

Are you designing a project? Do you need help with statistics?

Requesting statistical advice from The Centre for Applied Medical Statistics (CAMS) and information about their courses.


Scouting for great ideas

Fiona Bull and Priya Shimoga, who are R&D commercial trials managers at the Trust, have been appointed as two of the 10 new innovation scouts for the East of England.


“The Sorcerer's Apprentice - The Future of Medical Imaging”

NIHR Cambridge Biomedical Research Centre lecture series.
Thursday 8 July at 5.00 pm


“Stem Cells and Developmental Plasticity of the Placenta”

NIHR Cambridge Biomedical Research Centre lecture series.
Wednesday 7 July at 5.00 pm

 

> R&D news index